Przejdź do zawartości
Merck

Synthesis and evaluation of novel aromatic substrates and competitive inhibitors of GABA aminotransferase.

Bioorganic & medicinal chemistry letters (2007-11-09)
Michael D Clift, Richard B Silverman
ABSTRAKT

The design, synthesis, and evaluation of novel gamma-aminobutyric acid aminotransferase (GABA-AT) inhibitors and inactivators can lead to the discovery of new GABA-related therapeutics. To this end, a series of aromatic amino acid compounds was synthesized to aid in the design of new inhibitors and inactivators of GABA-AT. All compounds were tested as competitive inhibitors of GABA-AT. The amino acids with benzylic amines were also tested as substrates for GABA-AT. It was found that these compounds were all poor competitive inhibitors of GABA-AT, but some were substrates of the enzyme, suggesting their utility as scaffolds for potential GABA-AT mechanism-based inactivators. Computer modeling was used to rationalize the substrate activity of the various compounds.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Anthranilic acid, reagent grade, ≥98%
Sigma-Aldrich
Anthranilic acid, puriss. p.a., ≥99.5% (T)
Sigma-Aldrich
3-Aminobenzoic acid, 98%